Skip to main content

Articles

Page 62 of 74

  1. Studies have shown that nonspecific interstitial pneumonitis (NSIP), even when initially diagnosed as an idiopathic form of the disease, might be associated with an autoimmune background that later reveals its...

    Authors: WenBin Xu, Yi Xiao, HongRui Liu, MingWei Qin, WenJie Zheng and JuHong Shi
    Citation: BMC Pulmonary Medicine 2014 14:175
  2. Genetic factors play a role in the development and severity of chronic obstructive pulmonary disease (COPD). The pathogenesis of COPD is a multifactorial process including an inflammatory cell profile. Recent ...

    Authors: Xinyan Wang, Wan Li, Kun Huang, Xiaowen Kang, Zhaoguo Li, Chengcheng Yang, Xiaomei Wu and Lina Chen
    Citation: BMC Pulmonary Medicine 2014 14:173
  3. Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare lung disease caused by the autoantibody against granulocyte-macrophage colony stimulating factor (GM-CSF). The clinical course of aPAP is variable; in...

    Authors: Yuhei Kinehara, Hiroshi Kida, Yoshikazu Inoue, Masaki Hirose, Akihiko Nakabayashi, Yoshiko Takeuchi, Yoshitomo Hayama, Kiyoharu Fukushima, Haruhiko Hirata, Koji Inoue, Toshiyuki Minami, Izumi Nagatomo, Yoshito Takeda, Toshiki Funakoshi, Takashi Kijima and Atsushi Kumanogoh
    Citation: BMC Pulmonary Medicine 2014 14:172
  4. Due to the small amount of alveolar tissue in transbronchial biopsy (TBB) by forceps, the diagnosis of diffuse, parenchymal lung diseases (DPLD) is inherently problematic, with an overall low yield. The use of...

    Authors: Sergej Griff, Nicolas Schönfeld, Wilhelm Ammenwerth, Torsten-Gerriet Blum, Christian Grah, Torsten T Bauer, Wolfram Grüning, Thomas Mairinger and Henrik Wurps
    Citation: BMC Pulmonary Medicine 2014 14:171
  5. Activins are members of the TGF-ß superfamily of growth factors. First, we identified by expression array screening that activin-B and follistatin are upregulated in human idiopathic pulmonary fibrosis (IPF). ...

    Authors: Marjukka Myllärniemi, Jussi Tikkanen, Juha J Hulmi, Arja Pasternack, Eva Sutinen, Mikko Rönty, Outi Leppäranta, Hongqiang Ma, Olli Ritvos and Katri Koli
    Citation: BMC Pulmonary Medicine 2014 14:170
  6. Little is known about whether or how supplemental oxygen affects patients with pulmonary fibrosis.

    Authors: Amanda Belkin, Kaitlin Fier, Karen Albright, Susan Baird, Brenda Crowe, Linda Eres, Marjorie Korn, Leslie Maginn, Mark McCormick, Elisabeth D Root, Thomas Vierzba, Frederick S Wamboldt and Jeffrey J Swigris
    Citation: BMC Pulmonary Medicine 2014 14:169
  7. Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease of unknown causes. Three proteins (mammalian target of rapamycin, mTOR; zinc finger E-box-binding homeobox 1, ZEB1; Rho-associated, coiled-coil conta...

    Authors: Jong Sun Park, Hyo Jin Park, Young Sik Park, Sang-Min Lee, Jae-Joon Yim, Chul-Gyu Yoo, Sung Koo Han and Young Whan Kim
    Citation: BMC Pulmonary Medicine 2014 14:168
  8. The 6-Minute Walk Test (6MWT) is representative of daily-life activities and reflects the functional capacity of patients. The change of oxygen uptake (VO2) in the initial phase of low-intensity exercise (VO2 kin...

    Authors: Lukas Kern, Sophie Condrau, Florent Baty, Jan Wiegand, Arno JR van Gestel, Andrea Azzola, Michael Tamm and Martin Brutsche
    Citation: BMC Pulmonary Medicine 2014 14:167
  9. Inhaled allergen challenge is a standard method to study airway responses to inflammatory provocation and evaluate the therapeutic potential of novel anti-inflammatory compounds in asthma. MEM 1414 is a novel ...

    Authors: Brian R Leaker, Dave Singh, Ferhana Y Ali, Peter J Barnes and Brian O’Connor
    Citation: BMC Pulmonary Medicine 2014 14:166
  10. Cystic Fibrosis (CF) is a genetic disease with equal prevalence across sexes. However, women present worse lung function with faster function decline, earlier onset of bacterial colonization, more frequent pul...

    Authors: Adelaida Lamas, Luis Máiz, Marta Ruiz de Valbuena, José Manuel González-Casbas and Lucrecia Suárez
    Citation: BMC Pulmonary Medicine 2014 14:165
  11. Chronic obstructive pulmonary disease (COPD) has been classically divided into blue bloaters and pink puffers. The utility of these clinical subtypes is unclear. However, the broader distinction between airway...

    Authors: Craig P Hersh, Barry J Make, David A Lynch, R Graham Barr, Russell P Bowler, Peter MA Calverley, Peter J Castaldi, Michael H Cho, Harvey O Coxson, Dawn L DeMeo, Marilyn G Foreman, MeiLan K Han, Benjamin J Harshfield, John E Hokanson, Sharon Lutz, Joe W Ramsdell…
    Citation: BMC Pulmonary Medicine 2014 14:164
  12. The 2013 GOLD classification system for COPD distinguishes four stages: A (low symptoms, low exacerbation risk), B (high symptoms, low risk), C (low symptoms, high risk) and D (high symptoms, high risk). Asses...

    Authors: Lucas M A Goossens, Inge Leimer, Norbert Metzdorf, Karin Becker and Maureen P M H Rutten-van Mölken
    Citation: BMC Pulmonary Medicine 2014 14:163
  13. Wheezing during early life is a very common disorder, but the reasons underlying the different wheezing phenotypes are still unclear. The aims of this study were to analyse the potential correlations between t...

    Authors: Susanna Esposito, Valentina Ierardi, Cristina Daleno, Alessia Scala, Leonardo Terranova, Claudia Tagliabue, Walter Peves Rios, Claudio Pelucchi and Nicola Principi
    Citation: BMC Pulmonary Medicine 2014 14:162
  14. In epidemiological studies of asthma, questionnaires to differentiate asthmatics from non-asthmatics have proven to be cost-effective and convenient. The aim of this study was to analyze the association betwee...

    Authors: So Yeon Lim, Young Joo Jo and Eun Mi Chun
    Citation: BMC Pulmonary Medicine 2014 14:161
  15. Asthma is a chronic inflammatory airway disease characterized by reversible obstruction, inflammation and hyperresponsiveness to different stimulus. Aerobic and breathing exercises have been demonstrated to be...

    Authors: Karen B Evaristo, Milene G Saccomani, Milton A Martins, Alberto Cukier, Rafael Stelmach, Marcos R Rodrigues, Danilo F Santaella and Celso RF Carvalho
    Citation: BMC Pulmonary Medicine 2014 14:160
  16. Cystic fibrosis (CF) is characterized by recurrent respiratory infections and progressive lung disease. Whereas exercise may contribute to preserving lung function, its benefit is difficult to ascertain given ...

    Authors: Joseph M Collaco, Scott M Blackman, Karen S Raraigh, Christopher B Morrow, Garry R Cutting and Shruti M Paranjape
    Citation: BMC Pulmonary Medicine 2014 14:159
  17. Indacaterol is a long-acting beta-2 agonist for once-daily treatment of COPD. We evaluated the effects of indacaterol 150 μg on lung hyperinflation compared with placebo and open-label tiotropium 18 μg. We mea...

    Authors: Henrik Watz, Felix Krippner, Anne Kirsten, Helgo Magnussen and Claus Vogelmeier
    Citation: BMC Pulmonary Medicine 2014 14:158
  18. Many people with clinically significant chronic obstructive pulmonary disease (COPD) remain undiagnosed worldwide. There are a number of small studies which have examined possible methods of case finding throu...

    Authors: Rachel E Jordan, Peymané Adab, Sue Jowett, Jen L Marsh, Richard D Riley, Alexandra Enocson, Martin R Miller, Brendan G Cooper, Alice M Turner, Jon G Ayres, Kar Keung Cheng, Kate Jolly, Robert A Stockley, Sheila Greenfield, Stanley Siebert, Amanda Daley…
    Citation: BMC Pulmonary Medicine 2014 14:157
  19. Nasal potential difference (NPD) and intestinal current measurement (ICM) are functional CFTR tests that are used as adjunctive diagnostic tools for cystic fibrosis (CF). Smoking has a systemic negative impact on...

    Authors: Azadeh Bagheri-Hanson, Sebastian Nedwed, Claudia Rueckes-Nilges and Lutz Naehrlich
    Citation: BMC Pulmonary Medicine 2014 14:156
  20. The surgical resection of lung disrupts glucose homeostasis and causes hyperglycemia, as in any other major surgery or critical illness. We performed a prospective study where we carefully lowered hyperglycemi...

    Authors: Zdenek Ručka, Irena Koutná, Lenka Tesařová, Michaela Potěšilová, Stanislav Stejskal, Pavel Šimara, Petr Vaňhara, Jan Doležel, Vaclav Zvoníček, Oldřich Coufal and Ivan Čapov
    Citation: BMC Pulmonary Medicine 2014 14:155
  21. Exposure to perinatal anxiety affects disease susceptibility in offspring but studies on the association between perinatal anxiety and gene polymorphisms are lacking. This study aimed to elucidate the interact...

    Authors: Eun Lee, Hyoung Yoon Chang, Kyung-Sook Lee, Dong In Suh, Ho-Sung Yu, Mi-Jin Kang, In Ae Choi, Jinah Park, Kyung Won Kim, Youn Ho Shin, Kang Mo Ahn, Ja-Young Kwon, Suk-Joo Choi, Kyung-Ju Lee, Hye-Sung Won, Song I Yang…
    Citation: BMC Pulmonary Medicine 2014 14:154
  22. This retrospective cohort study aimed to determine if there are differences in cardiovascular co-morbidities, blood pressure (BP) and continuous positive airway pressure (CPAP) use between patients with positi...

    Authors: Yi-Chih Huang, Chun-Yao Lin, Chou-Chin Lan, Yao-Kuang Wu, Chor-Shen Lim, Chun-Yao Huang, Hsuan-Li Huang, Kuan-Hung Yeh, Yu-Chih Liu and Mei-Chen Yang
    Citation: BMC Pulmonary Medicine 2014 14:153
  23. Nucleotide-binding oligomerizing domain-1 (NOD1) is a cytoplasmic receptor involved in recognizing bacterial peptidoglycan fragments that localize to the cytosol. NOD1 activation triggers inflammation, antimic...

    Authors: Esmeralda Juárez, Claudia Carranza, Fernando Hernández-Sánchez, Elva Loyola, Dante Escobedo, Juan Carlos León-Contreras, Rogelio Hernández-Pando, Martha Torres and Eduardo Sada
    Citation: BMC Pulmonary Medicine 2014 14:152
  24. Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide. Patients with COPD frequently have systemic comorbidities that often require unscheduled hospitalization for exacerbation a...

    Authors: Wakae Hasegawa, Yasuhiro Yamauchi, Hideo Yasunaga, Mitsuhiro Sunohara, Taisuke Jo, Hiroki Matsui, Kiyohide Fushimi, Kazutaka Takami and Takahide Nagase
    Citation: BMC Pulmonary Medicine 2014 14:151
  25. Pulmonary exacerbation is one of the main risk factors for death in patients with cystic fibrosis. Several biomarkers have proven useful in the diagnosis and treatment of pulmonary exacerbations, although none...

    Authors: Rosa Maria Girón-Moreno, José L Justicia, Sara Yamamoto, Claudia Valenzuela, Carolina Cisneros, Rosa Mar Gómez-Punter, Gilda Fernandes-Vasconcelos and Julio Ancochea
    Citation: BMC Pulmonary Medicine 2014 14:150
  26. ATS/ERS Task Force has highlighted that special attention must be paid when FEV1 and FVC are concomitantly decreased (<5th percentile) and the FEV1/FVC ratio is normal (>5th percentile) because a possible cause o...

    Authors: Brigitte Chevalier-Bidaud, Karine Gillet-Juvin, Etienne Callens, Romain Chenu, Sémia Graba, Mohamed Essalhi and Christophe Delclaux
    Citation: BMC Pulmonary Medicine 2014 14:148
  27. Indoor particulate matter (PM) has been linked to respiratory symptoms in former smokers with COPD. While subjects with COPD and atopy have also been shown to have more frequent respiratory symptoms, whether t...

    Authors: Deepak A Kaji, Andrew J Belli, Meredith C McCormack, Elizabeth C Matsui, D’Ann L Williams, Laura Paulin, Nirupama Putcha, Roger D Peng, Gregory B Diette, Patrick N Breysse and Nadia N Hansel
    Citation: BMC Pulmonary Medicine 2014 14:147
  28. Strength training and neuromuscular electrical stimulation (NMES) are effective training modalities for improving muscle function, exercise performance and health status in individuals with COPD. The aim of th...

    Authors: Maurice JH Sillen, Frits ME Franssen, Anouk W Vaes, Jeannet ML Delbressine, Emiel FM Wouters and Martijn A Spruit
    Citation: BMC Pulmonary Medicine 2014 14:146
  29. Thyroid dysfunction has been described to be linked to a variety of cardiovascular morbidities. Through this pathway thyroid function might also be associated with cardiorespiratory function and exercise capac...

    Authors: Till Ittermann, Sven Gläser, Ralf Ewert, Stephan Felix, Henry Völzke and Marcus Dörr
    Citation: BMC Pulmonary Medicine 2014 14:145
  30. Viral pathogens were more commonly reported than previously estimated in community-acquired pneumonia (CAP) patients. However, the real role of virus was still controversial.

    Authors: Yangqing Zhan, Zifeng Yang, Rongchang Chen, Yutao Wang, Wenda Guan and Suishan Zhao
    Citation: BMC Pulmonary Medicine 2014 14:144
  31. Angiopoietin-1 (Ang-1) is an essential mediator of angiogenesis that establishes vascular integrity, and angiopoietin-2 (Ang-2) acts as its natural inhibitor. We considered that angiopoietin might be important...

    Authors: Kuk-Young Moon, PuReun-HaNeul Lee, Sung-Woo Park, Choon-Sik Park and An-Soo Jang
    Citation: BMC Pulmonary Medicine 2014 14:143
  32. Moderate-intensity exercise training improves skeletal muscle aerobic capacity and increased oxidative enzyme activity, as well as exercise tolerance in COPD patients.

    Authors: Chun-Hua Wang, Pai-Chien Chou, Wen-Ching Joa, Li-Fei Chen, Te-Fang Sheng, Shu-Chuan Ho, Horng-Chyuan Lin, Chien-Da Huang, Fu-Tsai Chung, Kian Fan Chung and Han-Pin Kuo
    Citation: BMC Pulmonary Medicine 2014 14:142
  33. Chronic thromboembolic pulmonary hypertension (CTEPH) is a long-term complication following an acute pulmonary embolism (PE). It is frequently diagnosed at advanced stages which is concerning as delayed treatm...

    Authors: Matthias Held, Alexander Hesse, Franziska Gött, Regina Holl, Gudrun Hübner, Philipp Kolb, Heinz Jakob Langen, Tobias Romen, Franziska Walter, Hans Joachim Schäfers, Heinrike Wilkens and Berthold Jany
    Citation: BMC Pulmonary Medicine 2014 14:141
  34. Sleep-related breathing disorders (SRBDs) provoke cognitive and structural brain disorders. Because these disorders have been associated with unsafe gait characterized by an increase in stride-to-stride variab...

    Authors: Sébastien Celle, Cédric Annweiler, Richard Camicioli, Jean-Claude Barthélémy, Frédéric Roche and Olivier Beauchet
    Citation: BMC Pulmonary Medicine 2014 14:140
  35. Idiopathic pulmonary fibrosis (IPF) is a distinct form of interstitial pneumonia with unknown origin and poor prognosis. Current pharmacologic treatments are limited and lung transplantation is a viable option...

    Authors: Kristin D Kistler, Luba Nalysnyk, Philip Rotella and Dirk Esser
    Citation: BMC Pulmonary Medicine 2014 14:139
  36. Solitary fibrous tumors of the pleura (SFTP) are rare and their long-term outcome is difficult to predict, as there are insufficient data which allow accurate characterization of the malignant variant. Thus th...

    Authors: Daniel Franzen, Matthias Diebold, Alex Soltermann, Didier Schneiter, Peter Kestenholz, Rolf Stahel, Walter Weder and Malcolm Kohler
    Citation: BMC Pulmonary Medicine 2014 14:138
  37. Fiberoptic bronchoscopy (FOB) is a useful diagnosis tool in low-burden countries for patients with suspected pulmonary tuberculosis (TB) who are smear-negative or sputum-scarce. This study sought to determine ...

    Authors: Pierre Le Palud, Vincent Cattoir, Brigitte Malbruny, Romain Magnier, Karine Campbell, Youssef Oulkhouir, Gérard Zalcman and Emmanuel Bergot
    Citation: BMC Pulmonary Medicine 2014 14:137
  38. The 6-minute walk test (6MWT) is used to measure exercise capacity and assess prognosis in interstitial lung disease (ILD). Although the 6MWT is usually considered to be a test of submaximal exercise capacity ...

    Authors: Anne E Holland, Leona Dowman, Julio Fiore Jr, Danny Brazzale, Catherine J Hill and Christine F McDonald
    Citation: BMC Pulmonary Medicine 2014 14:136
  39. Acute respiratory distress syndrome (ARDS) is characterized by overwhelming inflammatory responses and lung remodeling. We hypothesized that leukocyte infiltration during the inflammatory response modulates ep...

    Authors: Qiuhua Chen, Alice Aili Luo, Haibo Qiu, Bing Han, Bruce Hsin-Kuo Ko, Arthur S Slutsky and Haibo Zhang
    Citation: BMC Pulmonary Medicine 2014 14:135
  40. It is widely recognized that health-related quality of life (HRQL) is impaired in patients with Chronic Obstructive Pulmonary Disease (COPD), but there is a lack of research on longitudinal associations of COP...

    Authors: Margarethe E Wacker, Matthias Hunger, Stefan Karrasch, Joachim Heinrich, Annette Peters, Holger Schulz and Rolf Holle
    Citation: BMC Pulmonary Medicine 2014 14:134
  41. Being a contact of a pulmonary tuberculosis (TB) case is a risk factor for active and latent TB. The objective of this study is to determine the contact tracing yield using two different programmatic definitio...

    Authors: Carla Loredo, Michelle Cailleaux–Cezar, Anne Efron, Fernanda Carvalho Queiroz de Mello and Marcus Barreto Conde
    Citation: BMC Pulmonary Medicine 2014 14:133
  42. Inheritance of the F variant of alpha-1-antitrypsin is associated with normal circulating protein levels, but it is believed to be dysfunctional in its ability to inhibit neutrophil elastase and therefore has ...

    Authors: Nicola Jane Sinden, Firas Koura and Robert Andrew Stockley
    Citation: BMC Pulmonary Medicine 2014 14:132
  43. Chronic Obstructive Pulmonary Disease (COPD) is a growing worldwide problem that imposes a great burden on the daily life of patients. Since there is no cure, the goal of treating COPD is to maintain or improv...

    Authors: Annerika HM Slok, Johannes CCM in ’t Veen, Niels H Chavannes, Thys van der Molen, Maureen PMH Rutten-van Mölken, Huib AM Kerstjens, Guus M Asijee, Philippe L Salomé, Sebastiaan Holverda, Richard PN Dekhuijzen, Denise Schuiten, Gerard van Breukelen, Daniel Kotz and Onno CP van Schayck
    Citation: BMC Pulmonary Medicine 2014 14:131
  44. Air pollution has many negative health effects on the general population, especially children, subjects with underlying chronic disease and the elderly. The aims of this study were to evaluate the effects of t...

    Authors: Susanna Esposito, Carlotta Galeone, Mara Lelii, Benedetta Longhi, Beatrice Ascolese, Laura Senatore, Elisabetta Prada, Valentina Montinaro, Stefano Malerba, Maria Francesca Patria and Nicola Principi
    Citation: BMC Pulmonary Medicine 2014 14:130
  45. Serum KL-6 is a useful biomarker for the diagnosis of interstitial lung diseases (ILD). However, KL-6 has not been used to discriminate different types of ILD. Serum KL-6 concentrations can vary depending on a...

    Authors: Hiroshi Ohnishi, Shintaro Miyamoto, Shigeo Kawase, Tetsuya Kubota and Akihito Yokoyama
    Citation: BMC Pulmonary Medicine 2014 14:129
  46. Bacteremia by Streptococcus pneumoniae has been traditionally associated with poor outcomes in patients with pneumonia; however, data on its impact on outcomes are limited and are sometimes contradictory.

    Authors: Alberto Capelastegui, Rafael Zalacain, Amaia Bilbao, Mikel Egurrola, Luis Alberto Ruiz Iturriaga, Jose M Quintana, Ainhoa Gomez, Cristobal Esteban and Pedro P España
    Citation: BMC Pulmonary Medicine 2014 14:128
  47. Long term oxygen therapy (LTOT) has a strong evidence base in COPD patients with respiratory failure, but prescribing practices are recognized to need reform to ensure appropriate use and minimize costs. In th...

    Authors: Alice M Turner, Sourav Sen, Cathryn Steeley, Yasmin Khan, Pamela Sweeney, Yvonne Richards and Rahul Mukherjee
    Citation: BMC Pulmonary Medicine 2014 14:127
  48. Nitric oxide can be measured at multiple flow rates to determine proximal (maximum airway nitric oxide flux; JawNO) and distal inflammation (alveolar nitric oxide concentration; CANO). The main aim was to study t...

    Authors: Olaia Sardón, Paula Corcuera, Ane Aldasoro, Javier Korta, Javier Mintegui, José I Emparanza and Eduardo G Pérez-Yarza
    Citation: BMC Pulmonary Medicine 2014 14:126
  49. The effectiveness of clinic-based pulmonary rehabilitation in advanced COPD is well established, but few data exist for less severe patients treated in alternative settings. The purpose of this study was to in...

    Authors: Shefalee Amin, Marlon Abrazado, Molly Quinn, Thomas W Storer, Chi-Hong Tseng and Christopher B Cooper
    Citation: BMC Pulmonary Medicine 2014 14:125

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.5 - 5-year Impact Factor
    1.081 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    2,422,461 downloads
    1,250 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal